<html>
<head>PUBMED IDs for ESE3</head>
<body bgcolor='#C5F0F2'><h1>ESE3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11223187/'>Analysis of exonic splicing enhancers in the mouse gonadotropin-releasing hormone (GnRH) gene.</a> February 27  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11575921/'>SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.</a> September 29  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12419255/'>A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.</a> November 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/21318373/'>Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.</a> May 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21318334/'>Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22505649/'>ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.</a> August 11  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22733135/'>Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression.</a> July 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25950810/'>Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma.</a> May 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26607354/'>Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1.</a> June 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27197175/'>Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer.</a> May 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27732936/'>The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.</a> October 13  2016<br></body></html>
